glp-1 agonist gastric emptying Medicines And Gut Bacterial Overgrowth Reflections on the discovery GLP-1
Description
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 186,36 per year only 15,53 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
The drugs also seemed to have a reno-protective effect, reducing the composite kidney outcome by 17%
Home et al., 2009
[DOI] [PubMed] [Google Scholar] 106.Baek HS, Jeong C, Yang Y, Lee J, Lee J, Lee SH, et al
Compounded medications are not reviewed by the FDA for safety, effectiveness, or quality before they are dispensed
The first GLP-1 agonist was approved for use in Canada in 2017
